Anzeige
Mehr »
Login
Donnerstag, 28.03.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Spezial am Donnerstag: Rallye II. - Neuer Anstoß, News und was die Börsencommunity jetzt nicht verpassen will…
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
20 Leser
Artikel bewerten:
(0)

Pentwater Capital Management LP - Form 8.3 - Covidien Plc

FORM 8.3

                             IRISH TAKEOVER PANEL

   DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER
                           RULES, 2007 (AS AMENDED)

 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
                                     MORE

1. KEY INFORMATION

Name of person dealing (Note 1)                          Pentwater Capital
                                                         Management LP

Company dealt in                                         Covidien Plc

Class of relevant security to which the dealings being   $0.20 Ordinary
disclosed relate (Note 2)                                Shares

Date of dealing                                          December 16, 2014

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant
security dealt in(Note 3)

Class of relevant security:                   Ordinary shares

                         Interests            Short positions


                         Number        %        Number      %

(1) Relevant security  7,770,000     1.71%

(2) Derivatives
(other than options):

(3) Options and        5,980,000     1.32%    8,473,500   1.87%
agreements to
purchase/sell:

TOTAL:                13,750,000     3.03%     8,473,500  1.87%

(b) Interests and short positions in relevant securities of the company, other
than the class dealt in (Note 3)

Class of relevant security:

                                     Interests           Short positions


                         Number          %       Number        %

(1) Relevant
security

(2) Derivatives
(other than
options):

(3) Options and
agreements to
purchase/sell:

TOTAL:

3. DEALINGS (Note 4)

(a) Purchases and sales

            Purchase/sale             Number of relevant    Price per unit
                                          securities           (Note 5)

Purchase                              10,000              100.43 USD


(b) Derivatives transactions (other than options transactions)

    Product description      Nature of transaction   Number of   Price per unit
         e.g. CFD                  (Note 6)          relevant       (Note 5)
                                                    securities
                                                      (Note 7)


(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name e.g.  Writing,   Number of  Exercise   Type     Expiry    Option
   call option     selling,   securities  price     e.g.      date   money paid
                  purchasing,  to which           American,          / received
                    varying     option            European            per unit
                     etc.      relates              etc.


(ii) Exercising

             Product name                   Number of      Exercise price per
           e.g. call option                securities        unit (Note 5)


(d) Other dealings (including transactions in respect of new securities.
(Note4)

          Nature of transaction                Details        Price per unit
                (Note 8)                                     (if applicable)
                                                                 (Note 5)


4. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the
person disclosing and any other person relating to the voting rights of any
relevant securities under any option referred to on this form or relating to
the voting rights or future acquisition or disposal of any relevant
securities to which any derivative referred to on this form is referenced. If
none, this should be stated.


Is a Supplemental Form 8 attached? (Note 9)                         YES

Date of disclosure:                     December 17, 2014

Contact name:                           Neal Nenadovic

Telephone number:                       (312) 589-6405

If a connected EFM, name of offeree/
offeror with which connected

If a connected EFM, state nature of
connection (Note 10)

                                                         SUPPLEMENTALFORM8

                            IRISHTAKEOVERPANEL

DISCLOSUREUNDERRULE8.1ANDRULE8.3OFTHEIRISHTAKEOVERPANEL ACT,1997,TAKEOVER
                          RULES,2007(ASAMENDED)

                          DETAILSOFOPENPOSITIONS

 (ThisformshouldbeattachedtoForm8.1(a)&(b)(i),Form8.1(b)(ii)orForm8.3,as
                               appropriate)

OPENPOSITIONS(Note 1)

Productname,   Writtenor  Numberofrelevant  Exercise Type,e.g.    Expiry
e.g.calloption purchased  securitiestowhich price    American,    date
                          theoptionor       (Note 2) Europeanetc.
                          derivativerelates

Put option     written    4,700,000         57.50    American     17 Jan
                                            USD                   15

Put option     written    500,000           60.00    American     17 Jan
                                            USD                   15

Put option     written    100,000           62.50    American     17 Jan
                                            USD                   15

Put option     written    600,000           75.00    American     20 Dec
                                            USD                   14

Put option     written    80,000            67.50    American     17 Jan
                                            USD                   15

Put option     purchased  (500,000)         80.00    American     19 Dec
                                            USD                   14

Put option     purchased  (200,000)         82.50    American     17 Jan
                                            USD                   15

Put option     purchased  (1,500,000)       80.00    American     16 Jan
                                            USD                   15

Put option     purchased  (100,000)         90.00    American     15 Jan
                                            USD                   16

Put option     purchased  (243,500)         72.50    American     17 Jan
                                            USD                   15

Put option     purchased  (5,000,000)       75.00    American     17 Jan
                                            USD                   15

Put option     purchased  (330,000)         85.00    American     17 Jan
                                            USD                   15

Put option     purchased  (600,000)         80.00    American     17 Jan
                                            USD                   15

Notes

1. Wherethereareopenoptionpositionsoropenderivativepositions (exceptfor
CFDs),fulldetailsshouldbegiven.Fulldetailsofany existingagreementsto
purchaseortosellmustalsobegivenonthisform.

2. Forallpricesandothermonetaryamounts,thecurrencymustbestated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in
doubt, consult the Panel.
Großer Dividenden-Report 2024 von Dr. Dennis Riedl
Der kostenlose Dividenden-Report zeigt ganz genau, wo Sie in diesem Jahr zuschlagen können. Das sind die Favoriten von Börsenprofi Dr. Dennis Riedl
Jetzt hier klicken
© 2014 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.